WallStSmart

Ventas Inc (VTR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Ventas Inc stock (VTR) is currently trading at $82.70. Ventas Inc PE ratio is 153.15. Ventas Inc PS ratio (Price-to-Sales) is 6.75. Analyst consensus price target for VTR is $92.50. WallStSmart rates VTR as Hold.

  • VTR PE ratio analysis and historical PE chart
  • VTR PS ratio (Price-to-Sales) history and trend
  • VTR intrinsic value — DCF, Graham Number, EPV models
  • VTR stock price prediction 2025 2026 2027 2028 2029 2030
  • VTR fair value vs current price
  • VTR insider transactions and insider buying
  • Is VTR undervalued or overvalued?
  • Ventas Inc financial analysis — revenue, earnings, cash flow
  • VTR Piotroski F-Score and Altman Z-Score
  • VTR analyst price target and Smart Rating
VTR

Ventas Inc

NYSEREAL ESTATE
$82.70
$0.52 (0.63%)
52W$58.92
$88.37
Target$92.50+11.9%

📊 No data available

Try selecting a different time range

IV

VTR Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Ventas Inc (VTR)

Margin of Safety
-591.0%
Significantly Overvalued
VTR Fair Value
$12.40
Graham Formula
Current Price
$82.70
$70.30 above fair value
Undervalued
Fair: $12.40
Overvalued
Price $82.70
Graham IV $12.40
Analyst $92.50

VTR trades 591% above its Graham fair value of $12.40, indicating the stock may be overvalued at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Ventas Inc (VTR) · 10 metrics scored

Smart Score

55
out of 100
Grade: C
Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in market cap, operating margin, revenue growth. Concerns around return on equity and profit margin. Fundamentals are solid but monitor weak areas for improvement.

Ventas Inc (VTR) Key Strengths (4)

Avg Score: 8.8/10
Institutional Own.Quality
105.61%10/10

105.61% of shares held by major funds and institutions

Market CapQuality
$39.28B9/10

Large-cap company with substantial market presence

Operating MarginProfitability
20.30%8/10

Strong operational efficiency: $20 kept per $100 revenue

Revenue GrowthGrowth
21.40%8/10

Strong revenue growth at 21.40% annually

Ventas Inc (VTR) Areas to Watch (6)

Avg Score: 3.8/10
Return on EquityProfitability
2.17%1/10

Very low returns on shareholder equity

Profit MarginProfitability
4.32%2/10

Very thin margins, barely profitable

Price/SalesValuation
6.754/10

Premium valuation at 6.8x annual revenue

Price/BookValuation
3.134/10

Premium pricing at 3.1x book value

PEG RatioValuation
1.746/10

Growth is fairly priced, not cheap, not expensive

EPS GrowthGrowth
10.10%6/10

Solid earnings growth at 10.10%

Supporting Valuation Data

P/E Ratio
153.15
Overvalued
Forward P/E
135.14
Expensive
Trailing P/E
153.15
Overvalued
Price/Sales (TTM)
6.75
Premium
EV/Revenue
8.86
Premium

Ventas Inc (VTR) Detailed Analysis Report

Overall Assessment

This company scores 55/100 in our Smart Analysis, earning a C grade. Out of 10 metrics analyzed, 4 register as strengths (avg 8.8/10) while 6 fall into concern territory (avg 3.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Institutional Own., Market Cap, Operating Margin. Profitability is solid with Operating Margin at 20.30%. Growth metrics are encouraging with Revenue Growth at 21.40%.

The Bear Case

The primary concerns are Return on Equity, Profit Margin, Price/Sales. Some valuation metrics including PEG Ratio (1.74), Price/Sales (6.75), Price/Book (3.13) suggest expensive pricing. Growth concerns include EPS Growth at 10.10%, which may limit upside. Profitability pressure is visible in Return on Equity at 2.17%, Profit Margin at 4.32%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 2.17% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 21.40% strong but requiring continuation.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (Institutional Own., Market Cap) and negatives (Return on Equity, Profit Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

VTR Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

VTR's Price-to-Sales ratio of 6.75x sits near its historical average of 7.45x (37th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 49% below its historical high of 13.22x set in Oct 2011, and 104% above its historical low of 3.31x in Feb 2009.

Compare VTR with Competitors

Top REIT - HEALTHCARE FACILITIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Ventas Inc (VTR) · REAL ESTATEREIT - HEALTHCARE FACILITIES

The Big Picture

Ventas Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 5.8B with 21% growth year-over-year. Profit margins are thin at 4.3%, typical for companies in this phase that are reinvesting heavily in growth.

Key Findings

Cash Flow Positive

Generating 368M in free cash flow and 505M in operating cash flow. Earnings are translating into actual cash generation.

Low Return on Equity

ROE of 2.2% suggests the company isn't efficiently converting equity into profits.

Thin Margins Despite Growth

Profit margin at 4.3% is thin. While this is common for high-growth companies, margins need to expand as growth naturally decelerates.

What to Watch Next

Margin expansion: can Ventas Inc push profit margins above 15% as the business scales?

Growth sustainability: can Ventas Inc maintain 21%+ revenue growth, or will competition slow it down?

Valuation compression risk at a P/E of 153.2x. Any growth miss could trigger a sharp correction.

Sector dynamics: monitor REIT - HEALTHCARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Ventas Inc.

Bottom Line

Ventas Inc offers an attractive blend of growth (21% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions(61 last 3 months)

Total Buys
28
Total Sells
33

Data sourced from SEC Form 4 filings

Last updated: 12:59:00 PM

About Ventas Inc(VTR)

Exchange

NYSE

Sector

REAL ESTATE

Industry

REIT - HEALTHCARE FACILITIES

Country

USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.